TSS
AZN icon

Two Sigma Securities’s AstraZeneca AZN Stock Holding History

Two Sigma Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,350
Closed -$2.39M – 2856
2024
Q2 		$2.39M Sell
15,350
-17,650
-53% -$2.66M 0.03% 637
2024
Q1 		$4.47M Sell
33,000
-11,900
-27% -$1.58M 0.04% 442
2023
Q4 		$6.05M Buy
44,900
+8,850
+25% +$1.15M 0.06% 316
2023
Q3 		$4.88M Buy
+36,050
New +$4.92M 0.05% 372
2023
Q2 		– Sell
-4,850
Closed -$673K – 2774
2023
Q1 		$673K Sell
4,850
-2,500
-34% -$336K 0.01% 1065
2022
Q4 		$997K Buy
+7,350
New +$922K 0.03% 690
2022
Q3 		– Sell
-1,950
Closed -$258K – 2596
2022
Q2 		$258K Buy
+1,950
New +$256K 0.01% 1439
2021
Q4 		– Sell
-26,500
Closed -$3.18M – 1545
2021
Q3 		$3.18M Buy
26,500
+23,050
+668% +$2.68M 0.09% 197
2021
Q2 		$413K Buy
+3,450
New +$379K 0.01% 770
2021
Q1 		– Sell
-5,950
Closed -$595K – 878
2020
Q4 		$595K Buy
+5,950
New +$630K 0.01% 605
2019
Q2 		– Sell
-2,550
Closed -$206K – 2068
2019
Q1 		$206K Sell
2,550
-8,200
-76% -$646K ﹤0.01% 1465
2018
Q4 		$817K Buy
10,750
+750
+8% +$58.6K 0.01% 735
2018
Q3 		$791K Sell
10,000
-21,500
-68% -$1.63M 0.01% 1141
2018
Q2 		$2.21M Sell
31,500
-29,700
-49% -$2.14M 0.01% 862
2018
Q1 		$4.28M Buy
+61,200
New +$4.24M 0.02% 534

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Two Sigma Securities's AZN Position: Q1 2026 in Review

Two Sigma Securities opened a new position in AstraZeneca (AZN) in Q1 2026: 3,201 shares worth $631K. The stake represents 0.07% of the portfolio and ranks #382 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in AZN as recently as Q4 2024.

Two Sigma Securities first reported a position in AZN in Q1 2018 and has held it in 20 quarters since. The position peaked at $13.3M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Two Sigma Securities held 3,201 shares of AstraZeneca worth $631K as of Q1 2026.
  • AstraZeneca was a new Two Sigma Securities position in Q1 2026.
  • AstraZeneca made up 0.07% of Two Sigma Securities's portfolio in Q1 2026, its #382 holding.
  • Two Sigma Securities first reported a position in AstraZeneca in Q1 2018 and has held it in 20 quarters since.
  • Two Sigma Securities's AstraZeneca position peaked at $13.3M in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.